SBFMWSunshine Biopharma Inc.同业对比
Sunshine Biopharma Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SBFMW本股 | $124463#8 | 0.0x#7 | 0.0x#6 | 0.0x#1 | 4.1%#4 | -16.4%#10 | -17.2%#1 | -21.7%#2 | -63.1%#1 | — | -86.6%#3 | — |
| NXTS | $857466#2 | 0.0x#8 | 0.5x#12 | 4.1x#6 | -20.2%#5 | 22.9%#6 | -2014.3%#5 | -210.2%#11 | — | 4#2 | — | — |
| LNAI | $756678#3 | — | — | 14.6x#8 | — | 98.0%#2 | -16729.4%#6 | — | — | — | — | — |
| DCOY | $707600#4 | 0.0x#9 | 0.2x#11 | — | -100.0%#7 | 124.4%#1 | — | 289.8%#1 | — | — | — | — |
| LABT | $477492#5 | — | 0.1x#10 | — | — | 20.8%#7 | — | -88.8%#6 | — | — | — | — |
| CDT | $51842#10 | 0.0x#3 | 0.0x#2 | — | — | -120.3%#12 | — | -38.0%#3 | — | — | — | — |
| BFRIW | $386161#6 | — | 0.1x#8 | 0.0x#2 | 11.7%#3 | 40.7%#5 | -27.2%#2 | -176.9%#9 | -712.4%#3 | — | — | — |
| SXTPW | $216295#7 | — | 0.1x#9 | 0.2x#4 | 65.5%#2 | 7.3%#8 | -771.6%#3 | -281.7%#12 | -163.8%#2 | 6#1 | 9.2%#1 | — |
| CINGW | $79980#9 | — | 0.0x#5 | — | — | -35.6%#11 | — | -95.7%#7 | — | — | — | — |
| CDTTW | $5271#15 | 0.0x#2 | 0.0x#1 | — | — | -120.3%#12 | — | -38.0%#3 | — | — | — | — |
| ERNAW | $41300#11 | 0.0x#6 | 0.0x#7 | 0.1x#3 | 755.9%#1 | 68.4%#3 | -1601.2%#4 | -440.1%#13 | -1016.2%#4 | — | — | — |
| ASBPW | $32259#12 | 0.0x#4 | 0.0x#4 | 5.2x#7 | — | -1768.9%#14 | -312016.9%#7 | -208.2%#10 | — | — | — | — |
| REVBW | $25892#13 | 0.0x#5 | 0.0x#3 | — | — | 40.7%#4 | — | -88.5%#5 | — | — | -35.6%#2 | — |
| ADTX | $7588#14 | 0.0x#1 | — | 2.4x#5 | -97.6%#6 | -6.8%#9 | -612542.2%#8 | — | — | — | — | — |
| AAPG | $5.9B#1 | — | 164.2x#13 | 47.8x#9 | — | — | — | -153.5%#8 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-01。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议